Subscribe
HFX for PDN: A Nondrug Solution for Painful Diabetic Neuropathy with Niamh Pellegrini and Meredith Vornholt of Nevro

Outcomes Rocket

HFX for PDN: A Nondrug Solution for Painful Diabetic Neuropathy with Niamh Pellegrini and Meredith Vornholt of Nevro

August 25, 2021

HFX for PDN: A Nondrug Solution for Painful Diabetic Neuropathy with Niamh Pellegrini and Meredith Vornholt of Nevro

In this episode, we are privileged to host two outstanding healthcare leaders that can help us learn a new way of managing diabetic neuropathy. Niamh Pellegrini is the Chief Commercial Officer at Nevro, and Meredith Vornholt is the Senior Director of PDN Marketing.

Niamh and Meredith discuss HFX for PDN and how it can help patients suffering from diabetic neuropathy. They share insights on leveraging technology to help patient care, employer impact, challenges, patient anecdotes, and many more.

This HFX for PDN is the only spinal cord simulation approved by the FDA for manage pains associated with diabetic neuropathy.

Learn more about this innovative treatment in this exciting episode of the Outcomes Rocket podcast, so please tune in!

Click this link to the show notes, transcript, and resources: outcomesrocket.health

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Subscribe to Health Podcast Network

Proudly supported by:

cover
Y’all Means All Communities are powered by people—and the variety of lives, jobs, schedules, and skills keep cities buzzing. Providing care means healthcare has to show up for "y’all" no matter the gender identity, work schedule, or preferred language.